Cargando…

Elevated Plasma Big Endothelin-1 at Admission Is Associated With Poor Short-Term Outcomes in Patients With Acute Decompensated Heart Failure

Objective: We aimed to evaluate the association between plasma big endothelin-1 (ET-1) at admission and short-term outcomes in acute decompensated heart failure (ADHF) patients. Methods: In this single-center, retrospective study, a total of 746 ADHF patients were enrolled and divided into three gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Ran, Yang, Yan-min, Yu, Li-tian, Tan, Hui-qiong, Zhu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990871/ https://www.ncbi.nlm.nih.gov/pubmed/33778022 http://dx.doi.org/10.3389/fcvm.2021.629268

Ejemplares similares

Implementation of a heart failure educational intervention for patients with recent admissions for acute decompensated heart failure
por: Stahlman, Sarah, et al.
Publicado: (2023)

Associations between serum electrolyte and short-term outcomes in patients with acute decompensated heart failure
por: Zhao, Kai, et al.
Publicado: (2022)

Elevated plasma endothelin‐1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure
por: Zymliński, Robert, et al.
Publicado: (2020)

Early administration of ivabradine in patients admitted for acute decompensated heart failure
por: Yang, Teng-Yao, et al.
Publicado: (2022)

Identification of decompensation episodes in chronic heart failure patients based solely on heart sounds
por: Susič, David, et al.
Publicado: (2022)

Northern Territory Heart Failure Initiative–Clinical Audit (NTHFI–CA)–a prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the Northern Territory: study design and rationale
por: Iyngkaran, Pupalan, et al.
Publicado: (2014)

A new scoring system for predicting short‐term outcomes in Chinese patients with critically‐ill acute decompensated heart failure
por: Mo, Ran, et al.
Publicado: (2021)

Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure
por: Diaz-Riera, Elisa, et al.
Publicado: (2022)

Plasma Big Endothelin-1 Level Predicted 5-Year Major Adverse Cardiovascular Events in Patients With Coronary Artery Ectasia
por: Cai, Zhongxing, et al.
Publicado: (2021)

In-hospital Heart Rate Reduction With Beta Blockers and Ivabradine Early After Recovery in Patients With Acute Decompensated Heart Failure Reduces Short-Term Mortality and Rehospitalization
por: Faragli, Alessandro, et al.
Publicado: (2021)

Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF)
por: Ezekowitz, Justin A, et al.
Publicado: (2016)

Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials
por: Gong, Bojun, et al.
Publicado: (2016)

Case Report: Ambient Sensor Signals as Digital Biomarkers for Early Signs of Heart Failure Decompensation
por: Saner, Hugo, et al.
Publicado: (2021)

Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure: a meta-analysis
por: Chen, Shuai, et al.
Publicado: (2023)

Plasma Big Endothelin-1 Levels and Long-Term Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
por: Lyu, Si-qi, et al.
Publicado: (2022)

Prognostic relevance of elevated plasma osmolality on admission in acute decompensated heart failure with preserved ejection fraction: insights from PURSUIT-HFpEF registry
por: Nakagawa, Akito, et al.
Publicado: (2021)

Predictive Value of Plasma Big Endothelin-1 in Adverse Events of Patients With Coronary Artery Restenosis and Diabetes Mellitus: Beyond Traditional and Angiographic Risk Factors
por: Ma, Yue, et al.
Publicado: (2022)

Decompensated heart failure
por: Mangini, Sandrigo, et al.
Publicado: (2013)

Development and Validation of a Prediction Model for Acute Kidney Injury Among Patients With Acute Decompensated Heart Failure
por: Wang, Lei, et al.
Publicado: (2021)

Development and Validation of a Prediction Model for Irreversible Worsened Cardiac Function in Patients With Acute Decompensated Heart Failure
por: Wang, Lei, et al.
Publicado: (2021)

Feasibility and safety of 1-min sit-to-stand test in acute decompensated heart failure confirmed by lung ultrasound
por: Zhang, Xiu, et al.
Publicado: (2023)

Clinical characteristics and short-term outcomes in patients with elevated admission systolic blood pressure after acute ST-elevation myocardial infarction: a population-based study
por: Huang, Bi, et al.
Publicado: (2014)

In-hospital Routes of Acute Heart Failure Admissions During COVID-19
por: Ruocco, Gaetano, et al.
Publicado: (2020)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
por: Ibrahim, Ayman, et al.
Publicado: (2020)

C-reactive protein at discharge and 1-year mortality in hospitalised patients with acute decompensated heart failure: an observational study
por: Nishimoto, Yuji, et al.
Publicado: (2020)

How long before hospital admission do the symptoms of heart failure decompensation arise?
por: Born, Maraísa Carine, et al.
Publicado: (2019)

Reconciling Q waves and late gadolinium enhancement with no angiographic evidence of coronary disease: cardiac sarcoidosis presenting as decompensated heart failure
por: MORRISSEY,, RYAN P, et al.
Publicado: (2010)

Prognostic Value of β1 Adrenergic Receptor Autoantibody and Soluble Suppression of Tumorigenicity-2 in Patients With Acutely Decompensated Heart Failure
por: Sun, Yanxiang, et al.
Publicado: (2022)

Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI(2)P(2)S classification
por: de Oliveira Cardoso, Cristiano, et al.
Publicado: (2022)

Association between tricuspid annular systolic velocity and poor short-term prognosis in patients with acute decompensated heart failure
por: Zhao, Kai, et al.
Publicado: (2022)

Short-term rehospitalisation or death and determinants after admission for acute heart failure in a cohort of African patients in Port Harcourt, southern Nigeria
por: Maclean, R Akpa, et al.
Publicado: (2018)

SOFA score and short-term mortality in acute decompensated heart failure
por: Elias, Adi, et al.
Publicado: (2020)

Iatrogenic Decompensated Heart Failure
por: Tran, Patrick, et al.
Publicado: (2020)

Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East
por: Abi Khalil, Charbel, et al.
Publicado: (2017)

Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy
por: Fan, Peng, et al.
Publicado: (2021)

Risk factors and clinical outcomes of functional decline during hospitalisation in very old patients with acute decompensated heart failure: an observational study
por: Yaku, Hidenori, et al.
Publicado: (2020)

Relationship between Hypoalbuminemia on Admission and Long-term Mortality in Patients with Acute Decompensated Heart Failure
por: Yatsu, Shoichiro, et al.
Publicado: (2019)

Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure
por: Tamaki, Yodo, et al.
Publicado: (2021)

Geriatric Nutritional Risk Index at Hospital Admission or Discharge in Patients with Acute Decompensated Heart Failure
por: Ono, Masafumi, et al.
Publicado: (2023)

Elevated urinary albumin concentration predicts worse clinical outcomes in hospitalized acute decompensated heart failure patients
por: Wang, Yunhong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qd8f1ugha3v6j2k82rlddpqfpf